Transitioning cytomegalovirus viral load testing from a laboratory developed test to the cobas® CMV quantitative nucleic acid assay

2018 ◽  
Vol 90 (8) ◽  
pp. 1423-1426 ◽  
Author(s):  
Michael Payne ◽  
Linda Merrick ◽  
Tanya Lawson ◽  
Gordon Ritchie ◽  
Christopher Lowe
2018 ◽  
Vol 251 ◽  
pp. 75-79 ◽  
Author(s):  
Emilande Guichet ◽  
Laetitia Serrano ◽  
Christian Laurent ◽  
Sabrina Eymard-Duvernay ◽  
Christopher Kuaban ◽  
...  

2010 ◽  
Vol 31 (3) ◽  
pp. 119
Author(s):  
Geoff Higgins

Viral load testing is the quantitative measurement of viral nucleic acid in body fluids or tissues. In medical practice, viral load assays are commonly performed for HIV, Hepatitis B and Hepatitis C viruses. These assays are funded under the Medicare Benefits Schedule (MBS) system (Item numbers 69378/81/82, 69482/3 and 69488 respectively).


1999 ◽  
Vol 30 (2) ◽  
pp. 102-108
Author(s):  
Patricia Bereck Weikersheimer

2011 ◽  
Vol 14 (1) ◽  
pp. 23-23 ◽  
Author(s):  
Jane Greig ◽  
Philipp du Cros ◽  
Derryck Klarkowski ◽  
Clair Mills ◽  
Steffen Jørgensen ◽  
...  

2010 ◽  
Vol 201 (s1) ◽  
pp. S27-S36 ◽  
Author(s):  
Adrian Puren ◽  
Jay L. Gerlach ◽  
Bernhard H. Weigl ◽  
David M. Kelso ◽  
Gonzalo J. Domingo

2010 ◽  
Vol 14 (7) ◽  
pp. 852-858 ◽  
Author(s):  
M. Barton ◽  
S. Wasfy ◽  
D. Hébert ◽  
A. Dipchand ◽  
A. Fecteau ◽  
...  

1999 ◽  
Vol 123 (11) ◽  
pp. 1011-1014
Author(s):  
Frederick S. Nolte

Abstract Quantitative human immunodeficiency virus (HIV) type 1 RNA tests have been essential tools in increasing our understanding of HIV pathogenesis and antiretroviral therapy. The plasma HIV RNA level is among the most powerful predictive tests in modern medicine for disease progression and has rapidly become the standard of practice for guiding clinicians in initiating, monitoring, and changing antiretroviral therapy. In this article the scientific rationale and clinical indications for viral load testing in HIV infection are reviewed.


Sign in / Sign up

Export Citation Format

Share Document